Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 121 Carcinoma, Hepatocellular 69 Ovarian Neoplasms 64 Neoplasms 36 Carcinoma, Non-Small-Cell Lung 35 Fallopian Tube Neoplasms 29 Brain Neoplasms 24 Glioblastoma 23 Colonic Neoplasms 21 Breast Neoplasms 19 Neoplasm Metastasis 18 Endometrial Neoplasms 18 Uterine Cervical Neoplasms 15 Stomach Neoplasms 15 Rectal Neoplasms 15 Lung Neoplasms 14 Liver Neoplasms 11 Triple Negative Breast Neoplasms 10 Melanoma 8 Glioma 8 Carcinoma, Renal Cell 8 Carcinoma, Ovarian Epithelial 8 Biliary Tract Neoplasms 8 Recurrence 7 Colorectal Cancer Metastatic 7 Squamous Cell Carcinoma of Head and Neck 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Gastrointestinal Neoplasms 6 Advanced Solid Tumors 6 Small Cell Lung Carcinoma 5

Interventions

tocilizumab 1 atezolizumab 1 Tiragolumab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Liver Cancers × Bevacizumab × 1 year × Clear all

NCT04524871 2026-05-22

MORPHEUS-LIVER

Hoffmann-La Roche

Phase 1/2 Recruiting

Advanced Liver Cancers

Data powered by HemOnc (CC BY 4.0) Colophon ⚡